Stanford University: Psychotic Disorders trials
The registry lists 10 Psychotic Disorders studies with Stanford University as lead sponsor. 2 are open to participants now and 2 have results posted.
Phase 2 1Phase 3 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Incentives and Long-Acting Injectable Adherence After Involuntary HospitalizationEnrolling by invitationNCT07130500Not applicable
- Brain Stimulation to the Hippocampus in SchizophreniaRecruitingNCT07010614Not applicable
- Treatment of Psychotic Major Depression With MifepristoneTerminatedNCT00867360Phase 3Results posted
- Treatment of Schizoaffective Disorder Using MifepristoneTerminatedNCT00725270Phase 2/3Results posted
- Partners in Wellness: Evaluation of a Pay for Performance Program for High-Utilizers of Mental Health ServicesCompletedNCT06053346Not applicable
- Peripheral Immune System in Individuals With SchizophreniaCompletedNCT05109065
- Game-based Telehealth Therapeutic Intervention in First Onset PsychosisCompletedNCT04799717
- Genetics of Symptomatology and Treatment Response in Psychotic Major DepressionCompletedNCT00691535
- Clinical and Biological Characteristics of Psychotic DepressionCompletedNCT00576095
- Side Effects of Antipsychotic MedicationsCompletedNCT00363181